SHYFT Adds Pfizer's Former Head of Data and Analytics to Product Advisory Board
13 September 2017 - - Boston, Massachusetts-based life sciences analytics cloud platform SHYFT Analytics has appointed Marc Berger, MD to head its Real World Evidence product advisory board, the company said.
Berger, the former vice president of Real World Data and Analytics at Pfizer, joins SHYFT to help guide the strategic growth and momentum of the company's software suite of Real-World Evidence products and solutions for Life Sciences.
Berger brings nearly 20 years of experience in outcomes, research, and analytics in Life Sciences. Most recently, he served as vice president of Real World Data and Analytics at Pfizer, where he led an enterprise wide center of excellence focused on RWE-driven collaboration, engagement, and quality improvement.
Prior to Pfizer, he served in a variety of leadership roles including vice president, Global Health Outcomes at Eli Lilly and vice president, Outcomes Research and Management at Merck. 
SHYFT is an analytics cloud platform for life sciences with products and solutions designed specifically for the unique pharmaceutical, biotech, and medical device industry.
The company's Data Analytics Platform transforms healthcare data to accelerate commercial and clinical performance through converged insights. SHYFT is headquartered in Boston with offices in San Francisco and New York City.